---

Chronic Frontal Sinusitis - A Comprehensive Long-Answer Guide

---

1. INTRODUCTION AND DEFINITION

• CRSwNP - with nasal polyps
• CRSsNP - without nasal polyps

---

2. APPLIED ANATOMY OF THE FRONTAL RECESS

Boundaries of the Frontal Recess:

Key Points:

• The agger nasi cell is the anteriormost ethmoid cell and largely determines the anteroposterior distance from skull base to frontal beak
• The superior attachment of the uncinate process determines frontal drainage direction
• The anterior ethmoid artery lies on a mesentery in some patients ("supraorbital ethmoid cell" variant) - a surgical hazard
• An intersinus septal cell may displace the frontal recess laterally
• Proper CT review (identifying agger nasi cell, lamina papyracea, lateral lamella height, anterior ethmoid artery) forms the surgical "roadmap"

---

3. AETIOLOGY AND PATHOGENESIS

A. Anatomical Variations Obstructing the Frontal Recess

• Suprabulla cells, supraorbital ethmoid cells, frontal bulla cells, recessus terminalis
• Type 3 and 4 frontal ethmoidal cells are significantly associated with mucosal thickening
• Septal deviation, turbinate hypertrophy, middle turbinate pneumatization (concha bullosa)
• Agger nasi hyperplasia narrowing the frontal recess

B. Mucosal and Inflammatory Factors

• Ongoing mucosal inflammation is considered the most important factor - more so than anatomy alone
• Mucosal oedema narrows the already-tight frontal recess
• Eosinophilic CRS (with polyps, asthma, aspirin intolerance - the "Samter's triad") carries a worse prognosis
• Biofilm formation by bacteria reduces antibiotic efficacy

C. Microbiology

• Higher prevalence of anaerobic organisms
• Common organisms: Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis
• Post-surgical cases: MRSA, Pseudomonas aeruginosa, Enterobacter species

D. Post-Surgical Factors

• Scarring and stenosis secondary to previous surgery
• Retained uncinate process or residual cells in frontal recess
• Lateralization of the middle turbinate (seen in 36-78% of revision cases)
• Osteoneogenesis - new bone formation secondary to mucosal stripping over bare bone, persistent infection, and surgical trauma

E. Systemic Factors

• Diabetes mellitus
• Immune deficiency (patients with 3+ acute episodes/year should have immunology checked)
• Aspirin-exacerbated respiratory disease (AERD)
• Allergy / allergic rhinitis

---

4. CLINICAL FEATURES

Symptoms

• Frontal headache / pressure - the cardinal symptom; felt over the forehead, often worse on bending forward
• Nasal obstruction / congestion
• Mucopurulent nasal discharge (anterior rhinorrhoea or post-nasal drip)
• Reduced or absent sense of smell (anosmia/hyposmia)
• Facial pain / pressure over the frontal region

Important caveat: "Sinus headaches" are frequently mislabelled - true frontal sinus headaches are less common than tension headaches presenting in the same location. A thorough history is essential to differentiate.

Signs

• Tenderness on palpation over the medial aspect of the supraorbital margin (floor of frontal sinus)
• Nasal endoscopy: mucopurulent discharge from the middle meatus, nasal polyps, mucosal oedema
• Pale/oedematous turbinates if allergic component

---

5. INVESTIGATIONS

A. Nasal Endoscopy

• Allows direct visualization of the middle meatus and frontal recess area
• Identifies polyps, mucosal disease, anatomical variants (e.g., concha bullosa)
• Guides microbiological sampling

B. CT Scan (Gold Standard Imaging)

• Coronal CT is the investigation of choice
• Shows mucosal thickening, opacification, osteomeatal complex obstruction, frontal recess anatomy
• Essential pre-operative "roadmap" - identify: agger nasi, uncinate process, lamina papyracea, lateral lamella height, anterior ethmoid artery position
• Evaluate for complications: bone erosion, orbital extension, intracranial involvement

C. Plain X-Ray (Occipitomental / Caldwell view)

• Now largely superseded by CT
• Still used as a template for the frontal sinus outline in osteoplastic flap surgery (occipitofrontal view at 100 cm distance is life-size)

D. MRI

• Superior for soft tissue characterisation
• Identifies mucocele (hyperintense T2 signal), differentiates from tumour, demonstrates intracranial/intraorbital extension
• Useful when malignancy or fungal disease suspected

E. Ultrasonography

• Simple, non-invasive bedside tool
• Can assess fluid within sinus but limited spatial resolution; rarely used now

F. Microbiological Cultures

• Endoscopically-guided swabs from middle meatus
• Guide targeted antibiotic therapy

---

6. MEDICAL MANAGEMENT

A. Antibiotics

• Empirical broad-spectrum antibiotics based on local resistance patterns
• Long-term macrolide therapy (erythromycin, clarithromycin) at low dose for 12 weeks to 6 months - works not just via antibacterial action but by downregulating mucosal inflammation. Studies show benefit in non-eosinophilic CRS subtypes particularly; less clear benefit in eosinophilic CRS.
• Macrolides also help disperse bacterial biofilms

B. Topical Intranasal Corticosteroids

• First-line anti-inflammatory treatment
• Reduce mucosal oedema and polyp size
• Used long-term

C. Systemic (Oral) Corticosteroids

• Short courses for acute exacerbations or significant polyposis
• Valuable "bridge" therapy pre-operatively

D. Saline Nasal Irrigations

• Isotonic and hypertonic saline nasal douches
• Mechanically clear secretions, improve mucociliary transport, reduce oedema
• Important adjunct at all stages

E. Treating Underlying Conditions

• Allergen avoidance / antihistamines for allergic rhinitis
• Aspirin desensitisation for AERD
• Optimizing immunity in immunodeficient patients

---

7. COMPLICATIONS

Table: Complications of Frontal Sinusitis

Pott's Puffy Tumour

• Anterior spread of frontal sinusitis through the outer (anterior) table of the skull
• Causes a boggy subperiosteal abscess with osteomyelitis of the frontal bone
• A neurosurgical/ENT emergency

Mucocele / Pyocele

• Mucocele: epithelial-lined sac containing inspissated mucus, completely filling and expanding the sinus
• Caused by obstruction of the sinus ostium (inflammation, fibrosis, polyp, osteoma, previous surgery)
• Local bone resorption via prostaglandins, IL-1, TNF
• Can expand into orbit (proptosis/diplopia) or intracranially
• Treatment: endoscopic marsupialization (preferred) or open surgery

---

8. SURGICAL MANAGEMENT - INDICATIONS

Primary Indications for Surgery (before considering ESS)

1. Fungal disease in the frontal sinus
2. Barotrauma
3. Mucocele or pyocele
4. Osteoma causing obstruction with mucosal disease
5. Disfigurement or exophthalmos
6. Osteomyelitis, osteogenesis, tumour

Indication after Failed Medical Treatment

• Persistent symptoms despite maximal medical therapy (antibiotics + steroids + irrigation)

Key Principle (Modern Concept):

Treatment is directed towards the drainage pathway (frontal recess) rather than the sinus itself. Opacification of the frontal recess alone is not an indication for instrumentation - it often clears if the ostiomeatal complex is opened and disease treated medically.

Importantly: many patients appear to have had their disease initiated by unnecessary instrumentation of the frontal recess.

---

9. SURGICAL PROCEDURES - GRADUATED APPROACH

Graduated Table (Scott-Brown's Table 99.3)

---

A. Balloon Catheter Dilation (Balloon Sinuplasty)

• Concept: dilate the sinus ostium to restore aeration and mucociliary clearance, while preserving mucosa (reducing stenosis risk)
• May have a role in selected cases with limited disease
• Not appropriate for: nasal polyposis, osteoneogenesis, osteomyelitis, mucocele, or neoplasia
• Long-term data (>12 months) still limited; placebo effect not excluded
• Serious complications have been described

B. Draf Type I (Frontal Sinusotomy)

• Least invasive procedure
• Complete ethmoidectomy + removal of agger nasi, uncinate process, and anterosuperior ethmoid cells
• Clears obstruction inferior to the frontal ostium (within the frontal recess)
• Best when only minor frontal sinus pathology is present
• Insufficient for severe polyposis with asthma and aspirin intolerance

C. Draf Type II

• Type IIa: Widen the frontal ostium from lamina papyracea to the middle turbinate (using Kerrison or Hajek-Kofler punch)
• Type IIb: Extend to nasal septum; requires removing the anterior end of middle turbinate and drilling floor to midline
  • Indications for IIb: unilateral frontal ostium osteoneogenesis, inverted papilloma, osteoma, medially placed mucocele
  • Restenosis rate: IIb ~23% vs IIa ~3.6% (more drilling = more restenosis risk)

D. Draf Type III / Modified Endoscopic Lothrop Procedure (MELP)

• Also called: Frontal sinus drillout or Median drainage procedure
• Originally described by Lothrop in 1914 (external); Draf described the intranasal approach
• Creates a large common drainage pathway for both frontal sinuses by resecting:
  • Superior nasal septum (septal window ≥2 x 2 cm)
  • Frontal intersinus septum
  • Floor of both frontal sinuses

1. Complete sphenoethmoidectomy
2. Clear frontal recess, identify frontal ostium (frontal mini-trephines may help)
3. Create septal window (≥2 x 2 cm)
4. Trim anterior end of middle turbinate to skull base
5. Drill commences from one frontal recess, proceeds across midline to contralateral side
6. Identify first olfactory neurons (posterior limit of dissection) - creates the "frontal T"
7. Drill from contralateral side via septal window
8. Reduce frontal intersinus septum and frontal beak to join both sides
9. Preserve mucosa over posterior aspect of frontal ostium
10. Lower bone over anterior skull base projection to primary olfactory neuron

• Patency rate: ~95.9% (systematic review/meta-analysis)
• Failure rate: ~13.9% (80% of failures undergo revision MELP; remainder have obliteration)

E. Osteoplastic Flap Procedure (OPF)

• Wide exposure necessary, endoscopically inaccessible anatomy (large osteomas, lateral mucoceles, malignant tumours)
• Failed endoscopic procedures including MELPs
• Extensive frontal bone osteomyelitis
• Extensive neo-osteogenesis of frontal recess
• Diseased small underdeveloped sinuses (AP distance <8mm making MELP difficult)
• Frontal sinus fractures involving outflow tract

• Bicoronal (or brow / mid-forehead) incision
• Scalp flap reflected forward
• Template from plain X-ray (occipitofrontal view) used to outline the sinus
• Anterior table osteotomised and reflected inferiorly (hinge on periosteum)
• Full access to entire frontal sinus cavity

• All frontal sinus mucosa meticulously removed (residual mucosa leads to mucocele formation)
• Sinus obliterated with abdominal fat
• Gold standard for recalcitrant disease: success rates >90% at 8 years
• Long-term failure rate up to 25%

• CSF leak
• Persistent forehead numbness
• Severe headaches without evidence of recurrent disease
• Frontal bossing
• Supraorbital neuralgia
• Mucocele formation (from residual mucosa)
• Donor site complications (abdominal fat harvest)
• Difficulties with post-operative surveillance (CT follow-up needed)

In the modern endoscopic era, less than 2% of frontal sinus procedures in major centres are managed by OPF with obliteration. The ability to restore ventilation endoscopically from below while accessing from above via OPF has largely replaced pure obliteration.

---

10. REASONS FOR FAILURE OF FRONTAL SINUS SURGERY

1. Ongoing mucosal disease - persistent/recurrent nasal polyps, eosinophilic CRS, asthma
2. Incomplete dissection - retained uncinate process and residual cells impeding drainage
3. Lateralization of the middle turbinate - present in 36-78% of revision cases; the "frontal sinus rescue procedure" addresses this
4. Scarring and synechia - common; not always symptomatic but can obstruct recess
5. Osteoneogenesis - from mucosal stripping over bare bone; maintains inflammation → further stenosis
6. Complex frontal recess anatomy - the most common reason for surgical failure overall

---

11. POST-OPERATIVE CARE

• Nasal saline irrigations from early post-operative period - important to clear debris
• Topical intranasal steroids - continued long-term
• Regular endoscopic debridement during early post-operative period
• Medical management of underlying CRS continues
• Long-term follow-up essential (frontal sinus patency assessed endoscopically)

---

12. OUTCOMES

---

SUMMARY: KEY POINTS FOR EXAM

1. Chronic frontal sinusitis = >12 weeks persistent frontal sinus inflammation, usually part of CRS
2. Frontal recess is the key - the problem is the drainage pathway, not usually the sinus itself
3. Most important factor in aetiology: ongoing mucosal inflammation > anatomy alone
4. Bacteriology: anaerobes more prevalent than in acute sinusitis; post-surgical adds MRSA/Pseudomonas
5. Diagnosis: symptoms + endoscopy + coronal CT
6. Treatment is stepwise: maximal medical therapy first, then graduated surgical escalation
7. Medical therapy: antibiotics (macrolides for anti-inflammatory effect), intranasal steroids, saline irrigations
8. Graduated surgical approach: Balloon → Draf I → Draf IIa → Draf IIb → MELP/Draf III → OPF ± obliteration
9. MELP: patency ~96%, is minimally invasive alternative to obliteration - now preferred over OPF
10. OPF with obliteration: gold standard for recalcitrant disease but falling out of favour in endoscopic era
11. Mucosal preservation is paramount - bare bone → no cilia → osteoneogenesis → restenosis
12. Complications: mucocele, pyocele, Pott's puffy tumour, meningitis, subdural empyema, cavernous sinus thrombosis

---

---

CSF Rhinorrhoea - Comprehensive Long-Answer Guide

---

1. INTRODUCTION AND DEFINITION

1. The arachnoid and dura mater
2. The skull base bone
3. The paranasal sinus/nasal mucosa

• May cause ascending meningitis (major cause of mortality/morbidity)
• May allow development of pneumocephalus (air entering through the defect → brain compression)
• May be the presenting sign of serious pathology (tumour, hydrocephalus)

---

2. CLASSIFICATION (Box 48.1 - Cummings)

CSF RHINORRHOEA
├── I. TRAUMATIC (>90%)
│   ├── A. Accidental
│   │   ├── 1. Immediate (within 48 hours of trauma)
│   │   └── 2. Delayed (days to months after trauma)
│   └── B. Surgical (Iatrogenic)
│       ├── 1. Complication of neurosurgical procedures
│       │   ├── Transsphenoidal hypophysectomy
│       │   ├── Frontal craniotomy
│       │   └── Other skull base procedures
│       └── 2. Complication of rhinologic procedures
│           ├── Sinus surgery (FESS)
│           ├── Septoplasty
│           └── Other combined skull base procedures
│
└── II. NONTRAUMATIC (<10%)
    ├── A. Elevated Intracranial Pressure
    │   ├── 1. Intracranial neoplasm
    │   ├── 2. Hydrocephalus (communicating/obstructive)
    │   └── 3. Benign intracranial hypertension (BIH / pseudotumor cerebri)
    └── B. Normal Intracranial Pressure
        ├── 1. Congenital anomaly
        ├── 2. Skull base neoplasm (NPC, sinonasal tumours)
        ├── 3. Skull base erosive process
        │   ├── Sinus mucocele
        │   ├── Osteomyelitis
        │   └── Granulomatous diseases (e.g., GPA/Wegener's)
        └── 4. Idiopathic (true "spontaneous")

Key Epidemiological Points:

• 90% of CSF rhinorrhoeas are traumatic

• ~80% of all traumatic leaks follow accidental closed head injury
• CSF rhinorrhoea is noted in only 2-3% of serious head trauma; but skull base fractures carry a CSF fistula in 12-30% of cases

• 50% of fistulas from accidental trauma are at the anterior cranial base (cribriform plate most common)

• Most traumatic leaks become evident within 2 days and nearly all within 3 months
• Iatrogenic CSF leaks are now more common than accidental trauma; 25% of ENT surgeons reported an intraoperative CSF leak in 5 years; rate during FESS = ~0.5%

---

3. ANATOMY OF THE SKULL BASE RELEVANT TO CSF RHINORRHOEA

Common Sites of Skull Base Defects:

• Cribriform plate - most common; very thin (paper-thin laterally); passes olfactory nerve fibres
• Fovea ethmoidalis (ethmoid roof) - often asymmetric; injury risk during FESS
• Sphenoid sinus (planum sphenoidale, lateral recess, sella)
• Posterior wall of frontal sinus
• Temporal bone (tegmen tympani / mastoid) - presents as CSF otorrhoea → then rhinorrhoea via Eustachian tube

The lateral lamella of the cribriform plate is the thinnest bone in the skull base and is the most vulnerable area during endoscopic surgery.

---

4. PATHOPHYSIOLOGY

CSF Production and Dynamics:

• CSF is produced by the choroid plexus in the ventricles at 20 mL/hour in adults
• Circulates via foramina of Luschka and Magendie to subarachnoid spaces
• Total CSF volume = 140 mL (20 mL ventricles + 50 mL intracranial subarachnoid + 70 mL paraspinal)
• Normal CSF pressure: 4 cm H₂O (infants) to 14 cm H₂O (adults)
• Pressure maintained by balance between secretion (choroid plexus) and resorption (arachnoid villi)
• CSF secretion is constant → resorption rate determines pressure

For Active CSF Rhinorrhoea to occur, TWO conditions must coexist:

1. Structural defect - disruption of arachnoid, dura, bone, and mucosa
2. Pressure gradient - driving CSF outward (even low-pressure systems can leak if the defect is large)

Role of Elevated Intracranial Pressure (ICP) in "Idiopathic" CSF rhinorrhoea:

• A landmark finding: ALL patients who underwent lumbar puncture after successful endoscopic repair of nontraumatic CSF rhinorrhoea had elevated ICP (mean 26.5-32.5 cm H₂O)
• This implies occult ICP elevation is the driving force even in so-called "spontaneous" leaks
• The active CSF leak may actually be decompressing the raised ICP - so opening pressure at LP may be normal if actively leaking; it rises only after the leak is sealed
• Benign intracranial hypertension (BIH / idiopathic intracranial hypertension / pseudotumor cerebri):
  • Increased ICP with NO intracranial mass/hydrocephalus/dural sinus thrombosis
  • Features: headache, pulsatile tinnitus, papilloedema, visual disturbances, abducens palsy
  • Demographics: typically obese, middle-aged women - same demographics as spontaneous CSF leak
  • Associated with empty sella syndrome (pulsatile ICP transmitted to pituitary fossa → sella expansion)
  • These three - nontraumatic CSF rhinorrhoea, BIH, and empty sella - may be manifestations of the same underlying pathophysiological process

---

5. CLINICAL FEATURES

Symptoms:

• Unilateral watery nasal discharge - the cardinal symptom
• Salty or metallic taste - characteristic (CSF dripping into posterior pharynx)
• Often positional / intermittent - worse on bending forward, straining, coughing
• Headache - may reflect elevated ICP or the original trauma
• History of relevant aetiology: trauma, surgery, symptoms of raised ICP (visual blurring, tinnitus)

Important Symptom Caveat:

• CSF rhinorrhoea is often intermittent - may be absent at time of examination
• Volume may be very small because CSF drains from a low-pressure system
• The diagnosis can therefore be elusive and easily missed

Signs:

• Glistening, moist nasal mucosa on the side of the leak
• A stream of clear fluid may be seen (active leak)
• Small meningocele may be visible at the junction of the nasal septum and cribriform plate
• A 3 mm telescope may be passed into the sphenoid os to look for clear fluid

• Ask the patient to lean forward - CSF drips from the nostril (positive test)
• A negative test does NOT exclude CSF rhinorrhoea

• Drop bloody nasal discharge onto filter paper/handkerchief/white tissue
• If CSF is present: clear ring (halo) surrounds the central bloody spot as CSF diffuses faster
• Limitation: False positive with tears or saliva (both also produce a halo)
• Not a reliable test; of historical interest

• Papilloedema on fundoscopy
• Abducens (VI cranial nerve) palsy - false localizing sign of raised ICP
• Stigmata of maxillofacial trauma (traumatic causes)

---

6. DIAGNOSIS

Two-Step Diagnostic Process:

Step 1: Confirm the presence of CSF (biochemical markers) Step 2: Localise the skull base defect (imaging + intrathecal agents + endoscopy)

Step 1 - Biochemical Confirmation

Step 2 - Localisation of the Defect

Imaging:

Intrathecal Fluorescein:

• Dilute fluorescein injected intrathecally via lumbar puncture (0.1-0.5 mL of 10% solution diluted in 10 mL CSF → slow injection over 30 minutes)
• Active leak site glows bright green under blue-filtered endoscopy
• Allows precise localization and intraoperative confirmation
• Absence of fluorescein at end of repair confirms adequacy of closure
• CRITICAL WARNING: Serious neurological sequelae (seizures, paraplegia) have been reported with high doses - MUST use dilute solution only. Fluorescein is NOT FDA-approved for intrathecal use; used off-label.

---

7. DIFFERENTIAL DIAGNOSIS OF WATERY NASAL DISCHARGE

---

8. MANAGEMENT

A. Conservative (Non-Operative) Management

• Strict bed rest with head elevation for 1-2 weeks
• Lumbar catheter drainage (continuous, 10 mL/hour) OR serial spinal taps (intermittent LP)
  • Goal: decompress ICP → reduces pressure driving the leak → allows healing at defect site
  • Monitor: daily CSF cell count, protein, glucose, culture
  • Complications of lumbar drain: meningitis risk, severe headache from low ICP, pneumocephalus (air drawn in through defect if ICP falls too low), catheter-related infection
  • Avoid in markedly elevated ICP (herniation risk)
  • Routine prophylactic antibiotics NOT warranted (ineffective and may induce resistance); skin flora coverage (1st-generation cephalosporin) for puncture site
• Avoid coughing, sneezing, nose blowing, and Valsalva manoeuvres
• Stool softeners (prevent straining/Valsalva)

---

B. Surgical Management

Principle: Identify and seal the skull base defect with graft material

1. Transcranial (Intracranial) Repair

• Frontal craniotomy for cribriform plate / anterior skull base
• Extended approaches for sphenoid sinus defects
• Grafts used: fascia lata, muscle plugs, pedicled galeal flaps, fibrin glue
• Limitations:
  • Brain compression, hematoma, seizures, anosmia (olfactory nerve damage)
  • Failure rates may exceed 25% despite direct access
  • Now reserved for cases where endoscopic approach fails or anatomy precludes endonasal access
  • Largely replaced by endoscopic approaches

2. External (Extracranial) Transcranial - Historical

• External incision + transsinus access (pre-endoscopic era)
• Now replaced by endoscopic approach

3. Endoscopic Endonasal Repair - Current Gold Standard

• Excellent visualization (endoscope)
• Well tolerated by patient
• No external incision
• Post-repair monitoring via serial nasal endoscopy in office
• Outcomes excellent: 90% success rate (primary repair) and 97% success rate (secondary/revision repair) - large systematic review

• Pure endoscopic approach provides excellent access to:
  • Ethmoid roof (fovea ethmoidalis)
  • Cribriform plate (most common site)
  • Most of the sphenoid sinus
• Lateral sphenoid leaks: may need extended approach through medial pterygomaxillary space
• Frontal sinus posterior table defects: pure endoscopic approach without compromising frontal sinus outflow tract is usually sufficient; a trephine or osteoplastic flap may be needed for far lateral or posterior table defects

• Underlay: Graft is placed beneath the dura through the defect - best for larger defects, higher success rates
• Overlay: Graft placed on top of the bony defect edges - simpler, adequate for small defects

---

C. Postoperative Care

• Nasal packing removed several days after surgery
• Strict bed rest for several days post-op
• Antistaphylococcal antibiotics (prophylaxis against packing-related complications)
• Monitor for intracranial complications (haematoma) in ICU/stepdown for first 24 hours
• Patients instructed to avoid strenuous activity, sneezing, coughing for ~6 weeks
• Serial nasal endoscopy to monitor defect healing

• NOT routinely used (studies have NOT confirmed benefit in routine cases)
• Indicated selectively for:
  • High-flow CSF leaks
  • Suspected or confirmed elevated ICP
  • Tenuous repair
• Continued for 1-5 days post-op if used

• Acetazolamide (carbonic anhydrase inhibitor → reduces CSF production)
• Weight loss (in obese patients with BIH)
• CSF diversion procedures if above fail: ventriculoperitoneal shunt or lumboperitoneal drain

---

9. COMPLICATIONS OF CSF RHINORRHOEA

Prophylactic Vaccination:

• Streptococcus pneumoniae
• Haemophilus influenzae
• Meningococcus

Antibiotic Prophylaxis - Controversial:

• MacGee et al.: 14% meningitis WITH prophylaxis vs 5% WITHOUT (not statistically significant)
• Brodie meta-analysis (6 studies, 324 patients): 2.5% WITH prophylaxis vs 10% WITHOUT (P = 0.006)
• More recent large meta-analyses: no increased meningitis risk from skull base fractures with or without prophylaxis
• Current consensus: prophylactic antibiotics are NOT routinely recommended for post-traumatic CSF fistulae; may use 1st-generation cephalosporin for skin flora/wound coverage

---

10. SPECIAL SITUATIONS

Intraoperative CSF Leak During FESS:

• Recognized at the time: repair immediately using the above endoscopic techniques
• Small defect (<5mm): free mucosal graft + fibrin glue often sufficient
• Larger defect: formal repair with free graft layers + packing

Post-operative CSF Leak After FESS:

• May manage conservatively initially (bed rest, lumbar drainage)
• Most patients will require formal endoscopic repair

Nontraumatic / Idiopathic CSF Rhinorrhoea:

• Will NOT resolve spontaneously (unlike most traumatic leaks)
• Exclude underlying cause (brain tumour, hydrocephalus)
• Formal endoscopic repair warranted
• Elevated ICP must be addressed post-repair (acetazolamide, weight management, CSF diversion if needed)
• If not addressed → repair will fail due to ongoing high pressure

Frontal Sinus CSF Leaks:

• Most can be repaired endoscopically without compromising frontal sinus outflow tract
• Far lateral or posterior table defects: may need a trephine (small bur hole in anterior table) or osteoplastic flap for access

---

11. OUTCOMES

---

SUMMARY - KEY EXAM POINTS

1. Definition: CSF leak from subarachnoid space to sinonasal cavity through simultaneous arachnoid/dural/bony/mucosal defect + pressure gradient
2. Causes: Traumatic (>90%) - accidental > surgical; Nontraumatic (<10%) - BIH most important
3. Most common site: Cribriform plate (anterior skull base)
4. Key symptom: Unilateral watery nasal discharge with salty/metallic taste; positional/intermittent
5. Halo sign: Clear ring around bloody spot on paper - unreliable (false positives with tears/saliva)
6. Best biochemical marker: β-2 transferrin (specific, no false positives); β-trace protein (100% sensitivity and specificity)
7. Glucose test strips: NOT reliable - high false positive rate; abandoned
8. Imaging: HRCT (bony defect) + MRI (soft tissue, empty sella, meningoencephalocele)
9. Intrathecal fluorescein: Precise localization intraoperatively; use DILUTE only - neurological complications with high doses
10. Conservative treatment: Traumatic leaks - bed rest, head elevation, lumbar drainage, no straining
11. Surgical repair: Endoscopic endonasal is gold standard - 90% primary success, 97% revision
12. Graft: Free fat/fascia (underlay) + free mucosal graft (overlay) + fibrin glue + packing; vascularized flap for large/high-flow leaks
13. Key risk: >7 days of leakage = 8-10× meningitis risk → operate if not resolved
14. Prophylactic antibiotics: NOT routinely recommended for posttraumatic CSF fistulae
15. Spontaneous CSF rhinorrhoea: Associated with BIH, empty sella, elevated ICP - will NOT resolve spontaneously; treat ICP post-repair with acetazolamide or shunt
16. Vaccination: Pneumococcal, Hib, meningococcal - consider for all patients with CSF rhinorrhoea history

---